TY - JOUR TI - Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database AU - Koeks, Z. AU - Bladen, C.L. AU - Salgado, D. AU - Van Zwet, E. AU - Pogoryelova, O. AU - McMacken, G. AU - Monges, S. AU - Foncuberta, M.E. AU - Kekou, K. AU - Kosma, K. AU - Dawkins, H. AU - Lamont, L. AU - Bellgard, M.I. AU - Roy, A.J. AU - Chamova, T. AU - Guergueltcheva, V. AU - Chan, S. AU - Korngut, L. AU - Campbell, C. AU - Dai, Y. AU - Wang, J. AU - Barišić, N. AU - Brabec, P. AU - Lähdetie, J. AU - Walter, M.C. AU - Schreiber-Katz, O. AU - Karcagi, V. AU - Garami, M. AU - Herczegfalvi, A. AU - Viswanathan, V. AU - Bayat, F. AU - Buccella, F. AU - Ferlini, A. AU - Kimura, E. AU - Van Den Bergen, J.C. AU - Rodrigues, M. AU - Roxburgh, R. AU - Lusakowska, A. AU - Kostera-Pruszczyk, A. AU - Santos, R. AU - Neagu, E. AU - Artemieva, S. AU - Rasic, V.M. AU - Vojinovic, D. AU - Posada, M. AU - Bloetzer, C. AU - Klein, A. AU - Díaz-Manera, J. AU - Gallardo, E. AU - Karaduman, A.A. AU - Oznur, T. AU - Topalolu, H. AU - El Sherif, R. AU - Stringer, A. AU - Shatillo, A.V. AU - Martin, A.S. AU - Peay, H.L. AU - Kirschner, J. AU - Flanigan, K.M. AU - Straub, V. AU - Bushby, K. AU - Béroud, C. AU - Verschuuren, J.J. AU - Lochmüller, H. JO - Journal of Neuromuscular Diseases PY - 2017 VL - 4 TODO - 4 SP - 293-306 PB - IOS Press BV SN - 2214-3599, 2214-3602 TODO - 10.3233/JND-170280 TODO - corticosteroid; corticosteroid, Article; assisted ventilation; cardiomyopathy; child; cohort analysis; controlled study; cross-sectional study; data base; disease registry; drug efficacy; Duchenne muscular dystrophy; echocardiography; female; gene identification; gene mutation; genetic identification; good clinical practice; health care system; heart protection; human; major clinical study; male; muscle weakness; outcome assessment; preschool child; priority journal; respiratory failure; scoliosis; survival rate; adolescent; adult; Duchenne muscular dystrophy; genetics; infant; newborn; treatment outcome; young adult, Adolescent; Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Cross-Sectional Studies; Databases as Topic; Humans; Infant; Infant, Newborn; Male; Muscular Dystrophy, Duchenne; Treatment Outcome; Young Adult TODO - Background: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy (DMD) have indicated greater disease variability in terms of progression than expected. In addition, as average life-expectancy increases, reliable data is required on clinical progression in the older DMD population. Objective: To determine the effects of corticosteroids on major clinical outcomes of DMD in a large multinational cohort of genetically confirmed DMD patients. Methods: In this cross-sectional study we analysed clinical data from 5345 genetically confirmed DMD patients from 31 countries held within the TREAT-NMD global DMD database. For analysis patients were categorised by corticosteroid background and further stratified by age. Results: Loss of ambulation in non-steroid treated patients was 10 years and in corticosteroid treated patients 13 years old (p = 0.0001). Corticosteroid treated patients were less likely to need scoliosis surgery (p < 0.001) or ventilatory support (p < 0.001) and there was a mild cardioprotective effect of corticosteroids in the patient population aged 20 years and older (p = 0.0035). Patients with a single deletion of exon 45 showed an increased survival in contrast to other single exon deletions. Conclusions: This study provides data on clinical outcomes ofDMDacross many healthcare settings and including a sizeable cohort of older patients. Our data confirm the benefits of corticosteroid treatment on ambulation, need for scoliosis surgery, ventilation and, to a lesser extent, cardiomyopathy. This study underlines the importance of data collection via patient registries and the critical role of multi-centre collaboration in the rare disease field. © 2017 - IOS Press and the authors. All rights reserved. ER -